Studies on synthesis and influence of sterically driven Ni(II)-terpyridine (NNN) complexes on BSA/DNA binding and anticancer activity.

The present work demonstrates the synthesis, structural diversity and coordination behavior of some selected new Ni(II)-Tpy complexes. The structural analysis revealed the coordination of the selected terpyridine ligands with the core metal atom in two different modes via dimeric species (1:1 fashion) through the Cl-bridging and a bis(Tpy)-Ni complex (2:1 fashion). Perhaps the most striking manifestations of these Ni(II)-Tpy complexes are BSA/DNA binding ability and anticancer activity. In addition, the cytotoxicity studies of Tpy ligand (4-([2,2':6',2″-terpyridin]-4'-yl)phenyl 5-methylthiophene-2-carboxylate) and the Ni(II) complexes were carried out using lung cancer cell line (A549), breast cancer cell line (MCF-7) and normal cell line (Vero cell). The cytotoxicity results were compared with the cisplatin control group. Notably, bis-terpyridyl complex 3C (R = 4-([2,2':6',2″-terpyridin]-4'-yl)phenyl 4-isopropoxybenzoate) demonstrates better activity with the IC value of 23.13 ± 3 μm for A549 and 22.7 ± 3 for MCF-7. The DFT calculations reveal the significant energy differences of HOMO and LUMO for the ligands and their corresponding Ni(II) complexes. The Tpy ligands and Ni(II)-Tpy complexes were investigated for BSA binding and further all the Ni(II) complexes were analyzed for DNA binding studies.